SKOLNICK PHIL (Chief Scientific Officer) sold 2.2% of their position (480.00 shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $9.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2023ACC: 0001385508-23-000031
Officer· Chief Scientific Officer
Since Oct 2018
-480.00
Net shares
Net seller
$9.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
480.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−480.00
Price / share
$20.26
Trade value
$9.72K
% of position
2.2%
1/27/2023
22.03K→21.55K
Total
Net shares
−480.00
Net value
-$9.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2023 | S · Sale | −480.00 | $20.26 | $9.72K | 2.2% | 22.03K | 21.55K |
| Total | −480.00 | -$9.72K | ||||||
Derivative Transactions0
No derivative transactions reported